RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Minneapolis, MN · +112 more sites
5 recruiting migraine studies with a site in Minneapolis, MN.
Sponsor: Kallyope Inc.
Minneapolis, MN · +112 more sites
Sponsor: Pfizer
Minneapolis, MN · +55 more sites
Sponsor: Pfizer
Minneapolis, MN · +13 more sites
Sponsor: Kallyope Inc.
Minneapolis, MN · +112 more sites
Sponsor: University of Minnesota
Minneapolis, MN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.